Literature DB >> 9856220

[Economic evaluation of cardiology; background and application].

B A van Hout1, E S Goes, E W Grijseels, M A Quarles van Ufford.   

Abstract

Effectiveness research is increasingly attracting the attention not only of policy makers but also of the medical profession. Economic evaluation may provide structured information about the cost-effect balance of an intervention as compared with that of a different intervention. Costs can be subdivided into direct and indirect medical costs and direct and indirect non-medical costs. Effects are preferably expressed in life years gained (corrected for quality). A cost-effectiveness ratio indicates the additional costs per additional life year gained (corrected for quality). Economic evaluation can be performed using local, national or international research data. It may use studies that have been completed or in which the economic evaluation is included. A (planned) subgroup analysis may help to define a group of patients for whom the cost-effectiveness ratio is most favourable. The duration of a randomized clinical trial is usually relatively brief; with the aid of a mathematical model it is possible to collect the available information and to calculate extrapolations for longer periods.

Entities:  

Mesh:

Year:  1998        PMID: 9856220

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  2 in total

1.  The discount rate in the economic evaluation of prevention: a thought experiment.

Authors:  L Bonneux; E Birnie
Journal:  J Epidemiol Community Health       Date:  2001-02       Impact factor: 3.710

2.  Cost-effectiveness of intracoronary flow velocity measurements and myocardial perfusion scintigraphy for management of intermediate coronary lesions.

Authors:  S A J Chamuleau; M G W Dijkgraaf; B L F van Eck-Smit; J G P Tijssen; J J Piek
Journal:  Neth Heart J       Date:  2005-06       Impact factor: 2.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.